Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05463978 · ClinicalTrials.gov registry record
Sculptra Chart Review
A clinical trial, sponsored by Galderma R&D.
- Completed
- Registry status
- 498
- Enrollment target
NCT05463978: Completed study, sponsored by Galderma R&D.
NCT05463978 is a clinical trial that has completed, run by Galderma R&D. The registered enrollment target is 498 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05463978 has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- 498 participants
- Enrollment target
Study Summary
Multi-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas
Primary Outcome
Related AE was defined as a reasonable possibility that Sculptra Aesthetic or the injection procedure might have caused the event. AEs related to Sculptra Aesthetic or the injection procedure in non-facial areas were identified by review of the medical charts of between January 2018 to December 2020 and reported in this outcome measure.
Interventions
- DEVICE Sculptra Aesthetic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 498 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2022-10-14 |
What the finished NCT05463978 record still lists
NCT05463978 is an observational study that tracks outcomes without assigning an intervention. The registered 498 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Sculptra Aesthetic is the first listed.
NCT05463978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05463978 about?
NCT05463978 is a clinical study titled "Sculptra Chart Review". Multi-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas
What is the current status of trial NCT05463978?
This trial is currently completed. The enrollment target is 498 participants. The study started on 2022-07-14. Estimated completion is 2022-10-14.
What interventions are being tested in trial NCT05463978?
The interventions under investigation include: Sculptra Aesthetic (DEVICE).
Who is sponsoring clinical trial NCT05463978?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04137900 · 499 participants · Phase 1
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
- NCT06733480 · 499 participants · NA
Innovating Physical Therapy: A Pilot Study on Band Connect's Impact on Compliance, Satisfaction, and Revenue
- NCT03175224 · 497 participants · Phase 2
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- NCT05301816 · 497 participants · NA
PDN Post Market, Multicenter, Prospective, Global Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI